Article info
PDFPostScript
Letter
Randomised placebo-controlled trial of rituximab (anti-CD20) in active ulcerative colitis
- Correspondence to Dr Shomron Ben-Horin, Department of Gastroenterology, Sheba Medical Center, Tel-Hashomer, Ramat-Gan 52621, Israel; sben-horin{at}013.net.il
Citation
Randomised placebo-controlled trial of rituximab (anti-CD20) in active ulcerative colitis
Publication history
- First published May 25, 2011.
Online issue publication
April 18, 2016
Article Versions
- Previous version (18 April 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2011, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.